ATB-320
/ Autotelic
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 18, 2025
ATB-320-001A: Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Autotelicbio
New P1 trial • Solid Tumor
1 to 1
Of
1
Go to page
1